NASDAQ:SYNH - Syneos Health Stock Price, Forecast & News

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SYNH stock has decreased by 36.9% and is now trading at $36.18. View which stocks have been mosted impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Syneos Health.

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Syneos Health.

Syneos Health Inc (NASDAQ:SYNH) posted its quarterly earnings results on Thursday, February, 20th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.02. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.19 billion. Syneos Health had a return on equity of 10.12% and a net margin of 2.81%. The firm's revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.95 EPS. View Syneos Health's earnings history.

Syneos Health updated its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share guidance of $3.58-3.78 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.65. The company issued revenue guidance of $4.88-5.00 billion, compared to the consensus revenue estimate of $4.94 billion.

11 brokers have issued twelve-month target prices for Syneos Health's stock. Their forecasts range from $45.00 to $82.00. On average, they anticipate Syneos Health's share price to reach $65.70 in the next year. This suggests a possible upside of 81.6% from the stock's current price. View analysts' price targets for Syneos Health.

News stories about SYNH stock have trended very negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Syneos Health earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutSyneos Health.

Syneos Health saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 6,199,900 shares, a drop of 6.3% from the February 27th total of 6,620,000 shares. Based on an average daily volume of 1,569,000 shares, the short-interest ratio is currently 4.0 days. Approximately 10.0% of the shares of the stock are sold short. View Syneos Health's Current Options Chain.

Some companies that are related to Syneos Health include EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), PPD (PPD), Exelixis (EXEL), PRA Health Sciences (PRAH), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Intrexon (XON), Precigen (PGEN), STARPHARMA HOLD/S (SPHRY), Anavex Life Sciences (AVXL), Auxly Cannabis Group (CBWTF) and Luna Innovations (LUNA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Square (SQ), Netflix (NFLX), Constellation Brands (STZ), UnitedHealth Group (UNH), Verizon Communications (VZ), JD.Com (JD) and Micron Technology (MU).

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYNH stock can currently be purchased for approximately $36.18.

Syneos Health has a market capitalization of $3.77 billion and generates $4.68 billion in revenue each year. The company earns $131.26 million in net income (profit) each year or $2.83 on an earnings per share basis. Syneos Health employs 24,000 workers across the globe. View additional information about Syneos Health.

The official website for Syneos Health is http://www.syneoshealth.com/.

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at 919-876-9300 or via email at [email protected]